C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/18/2004	WO2004098490A2 Mesoderm and definitive endoderm cell populations
11/18/2004	WO2004098487A2 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 5 (tmprss5)
11/18/2004	WO2004098386A2 Oligonucleotides comprising a molecular switch
11/18/2004	WO2004098384A2 Parallel analysis of molecular interactions
11/18/2004	WO2004098377A2 Methods and compositions for diagnosis and therapy of parkin-associated disorders
11/18/2004	WO2004087281A9 Implementation of microfluidic components, including molecular fractionation devices, in a microfluidic system
11/18/2004	WO2004083853A3 Test system for the discovery of substances for the promotion of neuraxonal growth
11/18/2004	WO2004083225A3 Probe biochips and methods for use thereof
11/18/2004	WO2004080535A3 Methods and compositions for treating aids and hiv-related disorders using 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735, 1786, 10220, 17822, 33945, 43748, 47161, 81982, or 46777
11/18/2004	WO2004070062A3 Compositions and methods for diagnosing and treating cancers
11/18/2004	WO2004070059A3 Polymorphisms in the esr1 gene and diagnosis of an estrogen-sensitive disorder
11/18/2004	WO2004067759A3 Replication of nucleic acid arrays
11/18/2004	WO2004065616A3 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
11/18/2004	WO2004059008A3 Polymorhisms in the dihydropyrimidase gene
11/18/2004	WO2004050899A3 Method for in vitro selection of 2’-substituted nucleic acids
11/18/2004	WO2004048591A3 Methods for cohort selection and longevity studies
11/18/2004	WO2004042358A3 HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35
11/18/2004	WO2004037997A3 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof
11/18/2004	WO2004033710A3 Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol
11/18/2004	WO2004019893A3 Modulators of angiogenesis
11/18/2004	WO2004011902A3 Improved systems and methods for analysis of protein post-translational modification
11/18/2004	WO2004007673A3 Neuronal gene expression patterns
11/18/2004	WO2004005535A3 Pathogenicity proteins which can be used as targets for developing means for preventing and controlling bacterial infections
11/18/2004	WO2003100002A3 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
11/18/2004	WO2003095624A3 Liver inflammation predictive genes
11/18/2004	WO2003090694A3 Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases
11/18/2004	WO2003089665A8 Methods for measuring protein kinase and phosphatase activity
11/18/2004	WO2003087021A8 Nanoparticle delivery systems and methods of use thereof
11/18/2004	WO2003073067A3 Rna detection enzymes
11/18/2004	WO2003055982A3 Compositions and methods relating to endometrial specific genes and proteins
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040231009 Using variation in sensory organ developmental genes to diagnose and treat nervous system disorders; tissue engineering and gene therapy
11/18/2004	US20040231007 Assay for identifying compounds which affect stability of mRNA
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040230036 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection; solid phase synthesis
11/18/2004	US20040229894 Inhibition of human teomerase by a G-quadruplex-interaction compound
11/18/2004	US20040229886 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229843 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
11/18/2004	US20040229831 Compositions and methods for non-parenteral delivery of oligonucleotides
11/18/2004	US20040229828 Administering a therapeutically effective amount of at least one pharmacologically acceptable oligonucleotide at least 10 nucleotides in length
11/18/2004	US20040229805 Agents for producing the health-benefits of repeated exercise
11/18/2004	US20040229801 Provides anti-fungal compounds, including peptides and peptidomimetics having anti-fungal activity alone, and in combination with other agents that have anti-fungal activity, and methods of using the compounds for killing or inhibit growth of yeast, mold, slimes
11/18/2004	US20040229800 Stimulating nerve cell growth in a subject by administering a bastadin compound or its analogs
11/18/2004	US20040229796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229785 Screening methods to identify treatments for autoimmune disease
11/18/2004	US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/18/2004	US20040229382 Using immobilized biopolymers to characterize nucleic acids, proteins, antibodies, viruses, plastics, aptamers and tripartate multifunctional integrated constructs; biosensor and diagnostics; food processing and quality control
11/18/2004	US20040229367 Methods for monitoring multiple gene expression
11/18/2004	US20040229351 Adult multipotent human progenitor tissues for use in xenogenic tissue transplantation; tissue engineering; immunotherapy
11/18/2004	US20040229349 Microfluidic particle-analysis systems
11/18/2004	US20040229346 Micro-particle array analysis system, micro-particle array kit, and chemical analysis method
11/18/2004	US20040229333 Electroprocessed fibrin-based matrices and tissues
11/18/2004	US20040229317 Nucleotide sequences coding amino acid transport protein for use in identifying modulator for treatment of cell proliferative and tissue distribution disorders
11/18/2004	US20040229308 Kinesin polypeptide for use in identifying modulators for detection, treatment or prevention of cancer, nervous system and vesicular transport disorders
11/18/2004	US20040229302 Using analyte-specific oxidase immobilized on solid support comprised of protein-impermeable, hydrophilic matrix to determine glucose concentration of blood; diabetes screening
11/18/2004	US20040229298 Methods and compositions for treating cervical cancer
11/18/2004	US20040229292 Enhancing memory and learning via administering neurodegenerative cells and/or animal models fibroblast growth factor-18; gene therapy and tissue targeted therapy
11/18/2004	US20040229291 Screening and therapeutic methods relating to neurogenesis
11/18/2004	US20040229284 Multiplex analysis of proteins
11/18/2004	US20040229276 Method for screening antimycotic substances substances using essential genes from S. cerevisiae
11/18/2004	US20040229269 Hybridization-mediated analysis of polymorphisms
11/18/2004	US20040229268 Method and kit for identifying antibiotic-resistant microorganisms
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040229265 Amino-modified polysaccharides and methods of generating and using same
11/18/2004	US20040229264 Bioassay which utilizes interleukin allelic sequences and variable numbers of tandem repeats to diagnose and prognose cardiovascular disorders
11/18/2004	US20040229261 Comprises nucleotide sequences probes and primers which hybridize flaviviral 3' untranslated regions for use as diagnostic tools in viral disease detection/infection; point mutations
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229259 hybridization of template with probe via single reaction vessel to test quality of horticultural and agricultural products; high throughput assay for determining developmental or physiological staging of plants (freshness)
11/18/2004	US20040229258 Methods of detecting neurological disorders
11/18/2004	US20040229257 Methods for the diagnosis and treatment of epilepsy
11/18/2004	US20040229253 Compositions and methods for multiplex analysis of polynucleotides
11/18/2004	US20040229252 Using high density oligonucleotide probe arrays to identify and detect single nucleotide polymorphisms in lymphocyte receptors; diagnosing, treating and preventing autoimmune disorders
11/18/2004	US20040229248 cyanine, xanthene, porphyrin or coumarin dyes, used for marking probes, including nucleic acids and proteins
11/18/2004	US20040229247 Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces
11/18/2004	US20040229245 Enhancing accuracy of biochip transcriptional patterning via imaging hybridization on DNA chips; disease diagnostics and database scanning
11/18/2004	US20040229244 Using haptoglobin phenotype to predict effectiveness of free radical scavangers on preventing vascular disorders in diabetics
11/18/2004	US20040229243 MarA family helix-turn-helix domains and their methods of use
11/18/2004	US20040229242 Methods of capturing, detecting and quantifying RNA:DNA hybrids and a modified RNase H useful therein
11/18/2004	US20040229239 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants
11/18/2004	US20040229238 Comprises kinesin polypeptides for use as tools in identifying modulators for the treatment and prevention of cancer, neurological and vesicular transport disorders
11/18/2004	US20040229235 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
11/18/2004	US20040229234 Determining RNA expression patterns of tissues propagated in three dimension collagen matrix; genomics; disease diagnosis and transcriptional expression patterns
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229231 Using polynucleotides comprising deletions, insertions and/or single nucleotide polymorphisms to determine hereditary character of sample; genomics
11/18/2004	US20040229228 Il-1 genotype in early kidney allograft rejection
11/18/2004	US20040229227 Oligonucleotide primers having SEQ ID NOs. 1 to 21 and a process for detection of parasite Salmonella using oligonucleotide primers
11/18/2004	US20040229226 Analyte quantification apparatus comprised of solid support with designated test zones of immobilized capture and calibration ligands; determining cytokine, drug and nucleic acid concentration; diagnosing infection and disease
11/18/2004	US20040229225 Determination of a general three-dimensional status of a cell by multiple gene expression analysis on micro-arrays
11/18/2004	US20040229224 Monitoring variation in allelic and wild type expression profiles and drawing correlation between allelic transcription and disease; biochips and mutation identification
11/18/2004	US20040229222 An array of capture probes, hybridizing the target sequence to an array of capture probes to form a hybridization complex and determining the nucleotide at the detection position; amplification to prevent self-extension; sensitivity
11/18/2004	US20040229221 Using dual specificity probe to detect polymorphism in nucleotide sequences; restriction fragment length polymorphisms
11/18/2004	US20040229218 Using immunoglobulin which binds specifically to hepatitis envelope antigens E1 and E2 to detect viral infection
11/18/2004	US20040229217 Using glutamate transporter (BNPI)/(DNPI) proteins to identify agents which prevent and/or treat, vision, nervous system, autoimmune, inflammatory and viral disorders

1 ... 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 ... 3003